Hydrochloric Acid → (4-(6-(3-Aminopiperidin-1-yl)pyridin-3-ylamino)-6-(3-chloro-5-fluoro-4-hydroxyphenyl)quinolin-3-yl)(cyclopropyl)methanone hydrochloride

HRID 2271906노트

반응식

HRID 2271906 반응식
[NH2:1][CH:2]1[CH2:7][CH2:6][CH2:5][N:4]([C:8]2[N:13]=[CH:12][C:11]([NH:14][C:15]3[C:24]4[C:19](=[CH:20][CH:21]=[C:22]([C:25]5[CH:30]=[C:29]([F:31])[C:28]([OH:32])=[C:27]([Cl:33])[CH:26]=5)[CH:23]=4)[N:18]=[CH:17][C:16]=3[C:34]([CH:36]3[CH2:38][CH2:37]3)=[O:35])=[CH:10][CH:9]=2)[CH2:3]1.Cl>CO.C(OCC)C>[ClH:33].[NH2:1][CH:2]1[CH2:7][CH2:6][CH2:5][N:4]([C:8]2[N:13]=[CH:12][C:11]([NH:14][C:15]3[C:24]4[C:19](=[CH:20][CH:21]=[C:22]([C:25]5[CH:30]=[C:29]([F:31])[C:28]([OH:32])=[C:27]([Cl:33])[CH:26]=5)[CH:23]=4)[N:18]=[CH:17][C:16]=3[C:34]([CH:36]3[CH2:38][CH2:37]3)=[O:35])=[CH:10][CH:9]=2)[CH2:3]1

참가 물질

5

실험 절차

(4-(6-(3-aminopiperidin-1-yl)pyridin-3-ylamino)-6-(3-chloro-5-fluoro-4-hydroxyphenyl)quinolin-3-yl)(cyclopropyl)methanone (12 mg, 0.02 mmol) was suspended in methanol (1 mL) at 0° C. followed by dropwise addition of HCl in diethyl ether (2 M) until complete dissolution of the solid was observed. The solvent was removed under reduced pressure to afford the desired product (10 mg, 80%) as an orange-red solid: 1H NMR (500 MHz, MeOD) δ 9.39 (s, 1H), 8.27-8.19 (m, 2H), 8.13 (br s, 1H), 8.02 (d, J=8.8 Hz, 1H), 7.72 (dd, J=9.2, 2.7 Hz, 1H), 7.21-7.07 (m, 3H), 4.52 (d, J=10.8 Hz, 1H), 4.06-3.98 (m, 1H), 3.43-3.31 (m, 3H), 2.90-2.81 (m, 1H), 2.28-2.16 (m, 1H), 2.01-1.92 (m, 1H), 1.80-1.68 (m, 2H), 1.31-1.15 (m, 4H). ESI MS m/z 532 [C29H27ClFN5O2+H]+; HPLC 98.7% (AUC), tR=10.82 min.

후처리

  1. customThe solvent was removed under reduced pressure

출처 및 근거

ORD 기록
ord-0c9c213d81bb48bb9bbbbe3542bd475e
출처 데이터셋
uspto-grants-2015_09
특허 번호
US09120749B2

반응 노트

불러오는 중…